Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
1.330
0.00 (0.00%)
At close: Mar 9, 2026, 4:00 PM EDT
1.300
-0.030 (-2.26%)
After-hours: Mar 9, 2026, 5:42 PM EDT
Vivos Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 14 | 25 | 15 | 9 | 52 | 104 | |
| Market Cap Growth | -28.15% | 69.64% | 61.00% | -82.13% | -50.41% | - | |
| Enterprise Value | 23 | 21 | 16 | 5 | 25 | 111 | |
| Last Close Price | 1.33 | 4.29 | 12.44 | 10.05 | 56.25 | 147.75 | |
| PS Ratio | 0.78 | 1.68 | 1.08 | 0.58 | 3.07 | 7.99 | |
| PB Ratio | 4.34 | 3.18 | 36.24 | 1.93 | 2.03 | 5.67 | |
| P/TBV Ratio | - | 5.33 | - | 5.59 | 2.32 | 7.47 | |
| EV/Sales Ratio | 1.32 | 1.37 | 1.16 | 0.34 | 1.45 | 8.51 | |
| Debt / Equity Ratio | 4.94 | 0.19 | 4.85 | 0.50 | 0.05 | 0.07 | |
| Net Debt / Equity Ratio | 3.72 | -0.60 | 0.86 | -0.23 | -0.89 | -0.92 | |
| Net Debt / EBITDA Ratio | -0.61 | 0.45 | -0.02 | 0.05 | 1.22 | 2.12 | |
| Net Debt / FCF Ratio | -0.61 | 0.36 | -0.03 | 0.05 | 1.26 | 2.92 | |
| Asset Turnover | 0.85 | 1.16 | 1.13 | 0.68 | 0.57 | 0.80 | |
| Quick Ratio | 0.70 | 1.34 | 0.25 | 0.58 | 3.43 | 3.10 | |
| Current Ratio | 0.78 | 1.50 | 0.34 | 0.80 | 3.64 | 3.22 | |
| Return on Equity (ROE) | -335.45% | -266.25% | -521.22% | -157.19% | -92.31% | -143.62% | |
| Return on Assets (ROA) | -49.76% | -53.68% | -88.42% | -66.00% | -41.24% | -33.11% | |
| Return on Capital Employed (ROCE) | -89.60% | -108.40% | -502.60% | -362.40% | -74.40% | -45.90% | |
| Earnings Yield | -126.66% | -44.07% | -91.20% | -257.76% | -39.18% | -11.55% | |
| FCF Yield | -113.79% | -52.48% | -85.93% | -221.72% | -35.02% | -5.56% | |
| Buyback Yield / Dilution | -151.68% | -311.68% | -32.46% | -8.39% | -65.00% | -4.36% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.